Dipankar Seminar Report
Dipankar Seminar Report
RESEARCH, BHUBANESWAR
SEMINAR REPORT ON
A BIOMEDICAL SENSOR FOR DETECTION OF
CANCER CELLS BASED ON TERAHERTZ
METAMATERIAL ABSORBER
Submitted to - Submitted by –
Mrs. Ananya Dastidar Name - Dipankar Das
Mrs. Rashmi Rekha Sahoo Regd. No. - 2111100511
Mr. Naresh Chandra Naik Section & Group - A ‘2’
Semester - 7th
[1]
ACKNOWLEDGMENT
I would like to express my sincere gratitude to everyone who made this college
seminar a memorable and successful event. First and foremost, I extend my
heartfelt thanks to our esteemed HOS, Dr. Madhab Chandra Tripathy, for
providing us with this opportunity and for their constant support and
encouragement. I am deeply grateful to our faculty members, especially Mrs.
Ananya Dastidar, Mrs. Rashmi Rekha Sahoo and Mr. Naresh Chandra Naik
for their invaluable guidance and support throughout the preparation for this
seminar. Their insights and feedback have been crucial to my development as a
speaker. A special thank you to my fellow students for their enthusiasm and active
participation. Your engagement and thoughtful questions have made this seminar
a truly interactive and enriching experience. I also want to acknowledge the
efforts of the organizing committee, whose dedication and hard work behind the
scenes ensured the smooth execution of this event. Your teamwork and
commitment are greatly appreciated. Lastly, I would like to thank everyone who
attended and supported this seminar, including both teachers and students. Your
presence and encouragement have been a significant source of motivation for me.
Thank you all once again for making this seminar a successful and memorable
experience.
Dipankar Das
2111100511
[2]
ABSTRACT
[3]
CONTENTS
1. Introduction………………………………………………05
4. Working Principle………………………………………...11
5. Experimental Setup………………………………………13
6. Equivalent Model………………………………………...14
7. Results…………………………………………………….16
8. Contribution………………………………………………17
9. Challenges………………………………………………...19
10 . Limitations……………………………………………….20
11. Conclusion………………………………………………...21
12. FutureWork………………………………………………..22
13. References…………………………………………………23
[4]
1. INTRODUCTION
1.1 Background
[5]
1.3 Motivation
1.4 Objective
The primary objective of this project was to present the design and
development of a biomedical sensor based on a terahertz metamaterial
absorber for detecting cancer cells. The sensor leverages the unique
properties of metamaterials to achieve high sensitivity and specificity
in cancer detection. The report will cover the theoretical background,
sensor design, experimental setup, results, and a discussion of the
findings, as well as the potential implications for future research and
clinical applications.
[6]
2. THEORY AND BACKGROUND
2.1 Metamaterials
Metamaterials are artificially structured materials engineered to have properties
not found in naturally occurring materials. These properties arise from the
material's structure rather than its composition. Metamaterials can be designed to
interact with electromagnetic waves in unique ways, such as bending light
backward (negative refraction), focusing light beyond the diffraction limit, or
exhibiting a negative refractive index. These characteristics make them highly
suitable for applications in optics, antennas, and, as explored in this report,
biomedical sensors.
[7]
2.3 Terahertz Technology
Terahertz (THz) waves occupy the frequency range between 0.1 and 10 THz,
bridging the gap between the microwave and infrared regions of the
electromagnetic spectrum. THz waves are non-ionizing, meaning they do not
have enough energy to remove tightly bound electrons from atoms or molecules,
making them safe for biological applications. Moreover, THz waves have been
shown to interact differently with healthy and diseased tissues, including cancer
cells, due to variations in water content and molecular composition. This makes
THz technology particularly useful for non-invasive medical diagnostics.
[8]
3. DESIGN AND FABRICATION OF THE SENSOR
(a) (b)
Fig .3.1. Proposed structure. (a) Top view. (b) Side view
[9]
3.3 Metamaterial Design
The metamaterial design involves careful selection of the CRR dimensions,
spacing, and overall arrangement to achieve the desired resonance characteristics.
The design process includes computational modelling and simulation to optimize
the sensor's performance. Key design parameters include the radius of the rings,
the thickness of the dielectric and metallic layers, and the periodicity of the CRRs.
The resulting metamaterial exhibits a strong absorption peak at the target
frequency, which shifts in response to changes in the refractive index of the
surrounding medium, such as the presence of cancer cells.
Additionally, the design process includes rigorous testing and validation through
both simulation and experimental setups. The simulated results are cross-verified
with experimental data to ensure that the sensor operates as expected in real-
world conditions. This iterative process of design, simulation, and testing ensures
that the metamaterial sensor not only achieves the desired resonance
characteristics but also maintains stability and reliability across different
conditions. The final design is optimized for high sensitivity and specificity, with
the ability to detect changes in the refractive index down to minute levels, making
it a powerful tool for early cancer detection and other biomedical applications.
[10]
4. WORKING PRINCIPLE
[11]
Fig 4.2. Surface current distribution (a) with and (b) without concatenation
[12]
5. EXPERIMENTAL SETUP
5.3 Instrumentation
• Terahertz Source: Provides the necessary radiation for the sensor to
interact with the samples.
• Spectrometric System: Measures the reflected spectrum and analyzes the
absorption peaks.
• Data Analysis Software: Processes the spectral data to determine changes
in the refractive index and identify cancer cells.
• Application: Effectively detects cancer cells, validated various samples.
The equivalent circuit model simplifies the behavior of the metamaterial sensor
by representing it with basic electrical components like inductors, capacitors,
and resistors.
Inductors (L) simulate the magnetic response of the circular ring resonators.
Capacitors (C) represent the electric field coupling between the rings and the
dielectric layer.
Resistors (R) account for energy losses in the system.
[14]
7. RESULTS AND DISCUSSION
[15]
Fig 7.1. Parametric analysis of the proposed structure. (a) Unit cell dimensions.
(b) Height of the substrate. (c) Polarization angle.
The figure of merit quantifies the sensor’s performance, taking into account
factors such as sensitivity, resolution, and accuracy. A high figure of merit
indicates that the sensor is effective and efficient in detecting cancer cells.
𝑆
FoM = (8.1)
FWHM
[16]
8.CONTRIBUTION
Inductor (L1) with 0.5 nH: This component represents the inductive properties
of the circular ring resonators (CRRs) in the metamaterial. The inductance
captures the magnetic response of the CRRs to the incident terahertz wave.
Capacitor (C1) with 0.0037 fF: This represents the capacitive coupling
between the CRRs and the dielectric layer. It captures the electric field
interaction within the metamaterial, which is sensitive to changes in the
surrounding medium.
Resistor (R1) with 800 ohms: This component accounts for the resistive losses
within the system, which could be due to the material's inherent electrical
resistance and any other dissipative effects.
Voltage Source (V1) with AC 1 mV: The AC voltage source represents the
incident terahertz wave that is applied to the sensor. The frequency range is set
between 3.694 THz and 3.710 THz, which is close to the sensor's resonant
frequency.
Output Voltage (Vout): This is the measured voltage output, which
corresponds to the sensor's response to the incident terahertz wave.
[17]
.Fig 8.2. Frequecy Response of the Equivalent circuit
Operation:
When the terahertz wave (represented by the AC source) is applied to the
sensor, the resonant circuit (formed by L1, C1, and R1) will resonate at a
specific frequency. The resonance leads to a peak in the absorption spectrum,
which is detected as a voltage at Vout.
[18]
9. CHALLENGES
[19]
10. LIMITATIONS
10.1 Sample Variability:
o The sensor’s effectiveness can be influenced by variations in the
samples being tested. Factors such as sample thickness, preparation,
and homogeneity can affect the measured refractive index and,
consequently, the accuracy of cancer cell detection.
10.2 Environmental Conditions:
o The sensor's performance may be affected by environmental
conditions, such as temperature and humidity. Variations in these
conditions can alter the terahertz signal and affect the absorption
spectra, potentially leading to inaccurate results.
10.3 Sensitivity to Interference:
o The terahertz signal used for detection is susceptible to interference
from other materials or substances present in the testing
environment. This interference can affect the accuracy of the
measurement and make it challenging to distinguish between cancer
cells and other biological materials.
10.4 Cost and Complexity:
o The technology involved in fabricating and operating the TMA-
based sensor is advanced and costly. The high-quality materials,
precise fabrication techniques, and sophisticated detection systems
contribute to the overall expense. Reducing the cost while
maintaining high performance is a significant challenge.
10.5 Scalability:
o Scaling up the technology for widespread clinical use presents
challenges. While the sensor may perform well in a controlled
laboratory setting, adapting it for real-world clinical environments
and ensuring consistent performance across different applications
requires further development.
10.6 Regulatory and Validation Requirements:
o Before the sensor can be used in clinical settings, it must undergo
rigorous validation and approval processes. This includes
demonstrating its accuracy, reliability, and safety in detecting cancer
cells, as well as complying with regulatory standards.
[20]
11. CONCLUSION
The development of a biomedical sensor based on Terahertz Metamaterial
Absorbers (TMA) represents a significant advancement in the field of cancer
detection. This sensor leverages the unique properties of metamaterials,
particularly their ability to absorb electromagnetic radiation at specific
frequencies, to offer a highly sensitive and accurate means of identifying
cancerous cells. By utilizing circular ring resonators (CRRs) and a
combination of Gold and Gallium Arsenide (GaAs), the sensor achieves a peak
absorption of 99% at 3.71 THz, making it exceptionally effective at detecting
minute changes in the refractive index of biological samples.
The sensor's ability to operate at this specific frequency is particularly
advantageous because it aligns with the electromagnetic properties of cancer
cells, which exhibit distinctive refractive index characteristics. This specificity
allows for precise detection of various cancerous cells, enhancing the
diagnostic capabilities of the sensor. The reported sensitivity of 1447
GHz/RIU and a quality factor (Q-factor) of 92.75 further underscore the
sensor's performance, offering a robust solution for biomedical applications.
Despite its promising features, the sensor faces several challenges and
limitations. The precision required in fabrication and material quality is
critical, and any deviations can significantly impact sensor performance.
Additionally, the integration with detection systems and the impact of
environmental conditions on sensor accuracy must be carefully managed. The
high cost and complexity of the technology also present barriers to widespread
adoption, as does the need for rigorous validation and regulatory approval
before clinical use.
Overall, the TMA-based sensor represents a breakthrough in non-invasive
cancer detection technology. Its high sensitivity and specificity make it a
valuable tool for early diagnosis, which is crucial for improving treatment
outcomes. However, addressing the technical challenges and limitations is
essential for translating this technology from a laboratory setting to practical,
clinical applications. Ongoing research and development efforts are needed to
optimize the sensor's performance, reduce costs, and ensure its reliability and
accessibility for widespread use. By overcoming these hurdles, the TMA-
based sensor has the potential to revolutionize cancer diagnostics and
significantly impact patient care.
[21]
12. FUTURE SCOPE
1. Enhanced Sensor Performance:
• Optimization: Refine design parameters (e.g., CRR dimensions,
dielectric thickness) for improved sensitivity.
• Multi-Band Designs: Develop sensors with multiple frequency bands
for broader detection capabilities.
• Tunable Metamaterials: Create designs with dynamically adjustable
resonance frequencies.
2. System Integration:
• Detection Systems: Improve integration with advanced spectrometers
and imaging devices.
• Data Analysis: Implement machine learning for better data
interpretation and differentiation of cancer types.
3. Clinical and Regulatory:
• Clinical Trials: Conduct extensive trials to validate effectiveness and
safety.
• Regulatory Compliance: Navigate regulatory requirements and secure
necessary approvals.
4. Expanded Applications:
• Broader Uses: Investigate applications beyond cancer detection for
other diseases and health monitoring.
• Commercialization: Develop strategies for market adoption and
commercialization.
5. Education and Training:
• Knowledge Sharing: Disseminate information through workshops and
publications.
• Training: Develop programs to train users and technicians on sensor
operation and maintenance.
[22]
13. REFERENCES
[23]
[24]